Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients

Metabolism: Clinical and Experimental

Volumn 53, Issue 8, 2004, Pages 1013-1015

  Schreier, Laura ^a   González, Ana I ^a   Elbert, Alicia ^a   Berg, Gabriela ^a   Wikinski, Regina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CALCULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; LIPOPROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; ROC CURVE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 3342976205     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.01.001     Document Type: Article

References (11)

1. González A.I., Schreier L., Elbert A., et al. Lipoprotein alterations in hemodialysis Differences between diabetic and nondiabetic patients. Metabolism. 52:2003;116-121
2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497
3. Lu W., Resnick H.E., Jablonski K.A., et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes. Diabetes Care. 26:2003;16-23
4. Assman A.G., Jabs H., Kohnert U., et al. LDL cholesterol determination in blood serum following precipitacion of LDL with poly-vinil sulphate. Clin Chim Acta. 140:1984;77-83
5. 2+ precipitation for quantitation of high-density lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388
6. K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis. 41:(suppl 3):2003;S39-S58
7. Wanner C., Krane V. Non-HDL cholesterol A target of lipid-lowering in dialysis patients. Am J Kidney Dis. 41:(suppl 1):2003;S72-S75
8. Nishizawa Y., Shoji T., Kakiya R., et al. Non-HDL cholesterol as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int. 63:2003;S117-S120
9. Pedro-Boter J., Senti M., Rubiés-Pat J., et al. When to treat dyslipidaemia of patients with chronic renal failure on haemodialysis? A need to define specific guidelines. Nephrol Dial Transplant. 11:1996;308-313
10. Shoji T., Kawagishi T., Emoto M., et al. Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis. 153:2000;257-258
11. Shoji T., Nishizawa Y., Kawagishi T., et al. Intermediate-density lipoprotein as an independient risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol. 9:1998;1277-1284